» Articles » PMID: 24367631

Chronic Obstructive Pulmonary Disease (COPD) During the Two Last Years of Life--a Retrospective Study of Decedents

Overview
Journal PLoS One
Date 2013 Dec 25
PMID 24367631
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the management of patients suffering from chronic obstructive pulmonary disease (COPD) during the last years of life. The aim of the study was to describe how management of COPD is performed in Sweden during the last two years of life.

Methods: From the nationwide Cause of Death register all individuals with COPD as the underlying cause of death during two years were identified in one sparsely and one densely populated area of Sweden. Data were collected from medical records using a pre-defined protocol, especially developed for this purpose.

Results: Of 822 individuals with COPD as underlying cause of death, medical records from 729 were available. The COPD diagnosis was based on lung function measurements in approximately half of the patients and median age at COPD diagnosis was 74 years (range 34-95). Women died at younger age, median 78 years (range 52-96) than did men (80 years (51-99)). The median survival time from diagnosis to death was 6 years in men and women in both areas. Among women and men 8.3% and 4.3% were never smokers, respectively. The structure of COPD management differed between the two areas, with utilization of physiotherapists, dieticians and working therapists being more used in the northern area, likely because of differences in accessibility to care institutions.

Conclusions: In Sweden COPD is mostly diagnosed late in life and often not verified by lung function measurements. Opposite to the general population, women with COPD die at a lower age than men.

Citing Articles

Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study.

Larstad M, Almstrand A, Larsson P, Bake B, Larsson S, Ljungstrom E PLoS One. 2015; 10(12):e0144463.

PMID: 26656890 PMC: 4676630. DOI: 10.1371/journal.pone.0144463.

References
1.
Xu X, Li B, Wang L . Gender difference in smoking effects on adult pulmonary function. Eur Respir J. 1994; 7(3):477-83. DOI: 10.1183/09031936.94.07030477. View

2.
Gold D, Wang X, Wypij D, Speizer F, Ware J, Dockery D . Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 1996; 335(13):931-7. DOI: 10.1056/NEJM199609263351304. View

3.
Cleland J, Swedberg K, Cohen-Solal A, Dietz R, Follath F, Gavazzi A . The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology..... Eur J Heart Fail. 2000; 2(2):123-32. DOI: 10.1016/s1388-9842(00)00081-7. View

4.
Sundblad B, Larsson K, Nathell L . Low awareness of COPD among physicians. Clin Respir J. 2010; 2(1):11-6. DOI: 10.1111/j.1752-699X.2007.00020.x. View

5.
Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson A, Jonsson E . Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003; 97(2):115-22. DOI: 10.1053/rmed.2003.1446. View